Active Ingredient: POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
Proprietary Name: POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 1.18GM/250ML (4.72MG/ML);1.12GM/250ML (4.48MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218343
Product Number: 001
Approval Date: Jul 26, 2024
Applicant Holder Full Name: AMNEAL EU LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
